Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505310 · ClinicalTrials.gov registry record · NA
Biobehavioral Effects of Emotional Expression in Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 705
- Enrollment target
NCT00505310: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00505310 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 705 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505310, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 705 participants
- Enrollment target
Study Summary
The proposed study will assess the psychological and physiological benefits of an emotional expression intervention in patients with renal cancer. Patients will be randomly assigned to an emotional expression writing group or to a neutral writing group. This study will also evaluate the extent to which psychosocial factors mediate the intervention program and predict patients' recovery and adjustment to treatment. Potential mediators include level of cognitive processing, social networks/interactions, and sense of coherence and ability to find meaning in the illness experience. Specific objectives of the proposed research are: * To evaluate an emotional expression intervention in patients with renal cancer. Researchers will determine the extent to which an emotional expression writing-based intervention enhances adjustment during the first 12 months following diagnosis and treatment. Dimensions of adjustment will be assessed by examining indices of QOL, mental health, and stress (subjective symptoms of distress, perceived stress, and mood). * To determine the effects of an emotional expression writing-based intervention on immune function. The immune measures assessed in this study will include both general and autologous tumor-specific immune responses including cytotoxicity to K562 target cells; cytotoxicity to autologous tumor target cells; and functional assessment of type-1 and type-2 cytokines using autologous tumor and polyclonal stimulants. * To identify the psychosocial processes underlying the efficacy of the intervention.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 705 participants |
| Start Date | 2002-08-21 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00505310
The ClinicalTrials.gov registry entry for NCT00505310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 705 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00505310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00505310 about?
NCT00505310 is a clinical study titled "Biobehavioral Effects of Emotional Expression in Cancer". The proposed study will assess the psychological and physiological benefits of an emotional expression intervention in patients with renal cancer. Patients will be randomly assigned to an emotional expression writing group or to a neutral writing group. This study will also evaluate the extent to wh...
What is the current status of trial NCT00505310?
This trial is currently completed. It is a NA study. The enrollment target is 705 participants. The study started on 2002-08-21. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT00505310?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00505310?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.